| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.23 | 0.2 |